JP Morgan Chase
AYTU icon

JP Morgan Chase’s AYTU BioPharma AYTU Stock Holding History

JP Morgan Chase’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337 Hold
154
– – ﹤0.01% 7462
2026
Q1 		$405 Buy
+154
New +$394 ﹤0.01% 7196
2025
Q1 		– Sell
-75
Closed -$125 – 7324
2024
Q4 		$125 Sell
75
-238
-76% -$435 ﹤0.01% 6980
2024
Q3 		$736 Sell
313
-227
-42% -$588 ﹤0.01% 6756
2024
Q2 		$1.57K Sell
540
-80
-13% -$241 ﹤0.01% 6553
2024
Q1 		$1.89K Sell
620
-6,215
-91% -$17.8K ﹤0.01% 6582
2023
Q4 		$19.4K Buy
6,835
+4,647
+212% +$12.8K ﹤0.01% 6256
2023
Q3 		$5.91K Buy
2,188
+1,601
+273% +$2.8K ﹤0.01% 6348
2023
Q2 		$939 Buy
+587
New +$1.15K ﹤0.01% 6463
2021
Q2 		– Sell
-2,769
Closed -$421K – 6333
2021
Q1 		$421K Buy
2,769
+2,392
+634% +$380K ﹤0.01% 4783
2020
Q4 		$45K Buy
377
+202
+115% +$36.8K ﹤0.01% 5177
2020
Q3 		$42K Buy
175
+70
+67% +$18K ﹤0.01% 4989
2020
Q2 		$30K Buy
+105
New +$31.8K ﹤0.01% 4965
2019
Q3 		– Sell
-62
Closed -$22K – 5712
2019
Q2 		$22K Buy
+62
New +$23.6K ﹤0.01% 5414

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase's AYTU Position: Q2 2026 in Review

JP Morgan Chase held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 154 shares worth $337. The position accounts for ﹤0.01% of the portfolio, ranked #7462.

JP Morgan Chase first reported a position in AYTU in Q2 2019 and has held it in 14 quarters since. The position peaked at $421K in Q1 2021. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • JP Morgan Chase held 154 shares of AYTU BioPharma worth $337 as of Q2 2026.
  • JP Morgan Chase left its AYTU BioPharma share count unchanged in Q2 2026.
  • AYTU BioPharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7462 holding.
  • JP Morgan Chase first reported a position in AYTU BioPharma in Q2 2019 and has held it in 14 quarters since.
  • JP Morgan Chase's AYTU BioPharma position peaked at $421K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.